31st Annual International Prostate Cancer Update

Agenda

The International Prostate Cancer Update offers a comprehensive update on the treatment of prostate cancer. Join us from July 14-18, 2021, in Snowbird, Utah.

Wednesday, July 14, 2021, ALL TIMES MOUNTAIN TIME

Faculty Slide Review

Registration Desk Opens/Exhibitor Sign-in/Set Up

Welcome and Opening Remarks
E. David Crawford, MD, IPCU 31 Program Director
SESSION 1: Men’s Prostate Health
Moderators: Mark A. Moyad, MD, MPH, and E. David Crawford, MD

Prostate Cancer and the Role of Nutrition
Mark A. Moyad, MD, MPH

The Third Dimension in Prostate Cancer Diagnosis
Francisco G. La Rosa, MD

Early Diagnosis of Prostate Cancer: A Path Forward
E. David Crawford, MD

Highlights of Prostate Cancer Advances As Covered in ASCO-SEP: A Training and Board Certification Program for Medical Oncologists Worldwide
Marc B. Garnick, MD

Patient Advocacy: Advocate Perspective 
Wendy L. Poage, MHA

LUGPA Government Policy Panel
Moderator: R. Jonathan Henderson, MD (LUGPA President)
Panelists: Deepak A. Kapoor, MD, FACS (Chair, LUGPA Health Policy Committee); Mara R. Holton, MD (Vice-Chair, LUGPA Health Policy Committee); and Scott B. Sellinger, MD (LUGPA Secretary, Political Affairs Committee)

Welcome Reception – Golden Cliff
Overview of Resort and Activities

Open/On Own

Thursday, July 15, 2021, ALL TIMES MOUNTAIN TIME

Registration Desk Opens

Exhibits Open

Educational Product Theater – Golden Cliff
Treatment of mCRPC with LYNPARZA: An Oral Therapy for Patients with HRR Gene Mutations Following Progression on Enzalutamide or Abiraterone
Speaker: Lawrence Karsh, MD, FACS, CPI

Supported by AstraZeneca

Morning Break for Exhibits

SESSION 2: Biomarkers and Genetic Testing
Moderators: Alan H. Bryce, MD, and Leonard G. Gomella, MD, FACS

Prostate Cancer Early Detection 2021
Peter R. Carroll, MD, MPH

Active Surveillance Update 2021
Laurence Klotz, MD, FRCSC

Understanding and Hereditary Testing for the Urologist
Raoul S. Concepcion, MD, FACS

Germline Genetics in Prostate Cancer
Brian T. Helfand, MD, PhD

Risk Assessment (Early-in-Life PSA, PROMPT Test)
Gerald L. Andriole, Jr., MD

Use of Polygenic Risk Scores for Prostate Cancer Screening
Peter R. Carroll, MD, MPH

Review of Sentinel Assay
Laurence Klotz, MD, FRCSC

Panel Discussion
Moderator: Leonard G. Gomella, MD

Morning Break for Exhibits

SESSION 3: Practice Management
Moderator: R. Jonathan Henderson, MD

Overview/Update of LUGPA
R. Jonathan Henderson, MD

Starting an Advanced Prostate Cancer Clinic
Moderator: Scott B. Sellinger, MD
Panelists: Raoul S. Concepcion, MD; R. Jonathan Henderson, MD; and Lawrence Karsh, MD, FACS, CPI

Negotiating Pay for Call Contracts with Hospitals
Evan R. Goldfischer, MD, MBA (LUGPA President-Elect)

Private Equity Panel Discussion
Moderator: Deepak A. Kapoor, MD, FACS
Panelists: Peter M. Knapp, MD, FACS; David M. Albala, MD; and Scott B. Sellinger, MD

How to Optimize a Telehealth Visit
Evan R. Goldfischer, MD, MBA

Telemedicine and Post-COVID Treatment Panel Discussion
Moderator: Mara R. Holton, MD
Panelists: David M. Albala, MD, Evan R. Goldfischer, MD, MBA, R. Jonathan Henderson, MD, and Lawrence Karsh, MD, FACS, CPI

Adjourn

Educational Product Theater – Golden Cliff
Impact of Late LHRH Agonist Dosing on Testosterone Suppression and Relevance of 6-Month Dosing in Current Pandemic Environment & Beyond
Speaker: E. David Crawford, MD

Supported by Tolmar Pharmaceuticals

SESSION 4: Localized Prostate Cancer, Including ADT and Radiation Oncology
Moderators: Laurence Klotz, MD, FRCSC; James A. Eastham, MD, FACS; and Steven E. Finkelstein, MD, FACRO

Updates in ADT: What’s New
Laurence Klotz, MD, FRCSC

ADT Plus Radiation: A Radiation Oncologist’s Perspective
Steven E. Finkelstein, MD, FACRO

Break and Visit Exhibits

LUGPA ADT Panel Discussion
Moderator: Raoul S. Concepcion, MD, FACS
Panelists: Scott B. Sellinger, MD; R. Jonathan Henderson, MD; Peter M. Knapp, MD, FACS; and David M. Albala, MD

Active Surveillance in Favorable Intermediate-Risk Prostate Cancer
James A. Eastham, MD, FACS

Can We Trust the TRUS Biopsies? Case Presentations and Discussion
Francisco G. La Rosa, MD

Panel Discussion: Management of High-Risk, Non-Metastatic Prostate Cancer – The Case for Surgery
Moderator: James A. Eastham, MD, FACS
Panelists: Francisco G. La Rosa, MD; Steven E. Finkelstein, MD, FACRO; and Peter R. Carroll, MD, MPH

Management of Biochemical Recurrence After Surgery or Radiation
Peter R. Carroll, MD, MPH

Contemporary Brachytherapy: A View from the ABS
Brian J. Moran, MD

Updates in Radiation Oncology: A View from ACRO
Steven E. Finkelstein, MD, FACRO

Panel Discussion
Moderator: Steven E. Finkelstein, MD, FACRO
Panelists: James A. Eastham, MD, FACS; Francisco G. La Rosa, MD; and Peter R. Carroll, MD, MPH

LUGPA Sponsored Cocktail Reception – Conference Center Terrace
Guest Speaker: Congressman Greg Murphy, MD

Open/On Own

Faculty Dinner – Aerie Mountain Room

Friday, July 16, 2021, ALL TIMES MOUNTAIN TIME

Registration Desk Opens

Exhibits Open

Educational Product Theater – Golden Cliff
ERLEADA: For the Treatment of Patients with Metastatic Castration-Sensitive Prostate Cancer (mCSPC) and Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC)
Lawrence Karsh, MD, FACS, CPI and Steven E. Finkelstein, MD, FACRO

Supported by Janssen Biotech

Morning Break for Exhibits

SESSION 5: Next Generation Imaging: Focus on PSMA
Support by AAA, a Novartis Company, Lantheus, and Telix Pharmaceuticals

Moderator: Phillip J. Koo, MD

Next Generation Imaging
Phillip J. Koo, MD

Part 1: Current Status of PSMA Diagnostics

8:40am–9:00am
Ga-PSMA-11
Jérémie Calais, MD, MSc

9:00am–9:20am
Pyl
E. David Crawford, MD 

9:20am–9:35am
Panel Discussion
Moderator: Phillip J. Koo, MD

Part 2: Patient Management at Initial Diagnosis and Biochemical Recurrence

9:35am–9:50am
Impact at Initial Diagnosis
Peter R. Carroll, MD, MPH

9:50am–10:05am
Oligometastatic Disease
Robert E. Reiter, MD 

10:05am–10:20am
Radiation Oncology Perspective
Steven E. Finkelstein, MD, FACRO 

10:20am–10:55am
Panel Discussion with Cases
Moderator: Phillip J. Koo, MD

Break to Visit Exhibits

Part 3: Current Trials with PSMA and Other Therapies
Moderator: Daniel P. Petrylak, MD

11:10am–11:20am
VISION Trial
Daniel J. George, MD

11:20am–11:30am
Future Trials with Lutetium-177
Daniel P. Petrylak, MD

11:30am–11:40am
Radium-223 Trial Updates
Daniel P. Petrylak, MD

11:40am–11:50am
Integrating Theranostics Into a Group Practice  
David M. Albala, MD

11:50am–12:10pm
Panel Discussion
Moderator: Phillip J. Koo, MD

Adjourn

Educational Product Theater – Golden Cliff
NUBEQA® (darolutamide) In Non-Metastatic CRPC: A Clinical Review of the Efficacy and Tolerability of NUBEQA As a First-Line Option In Non-Metastatic CRPC
Speaker: Scott B. Sellinger, MD

Supported by Bayer Oncology

Afternoon Break for Exhibits

SESSION 6: Advanced Imaging
Moderators: Gerald L. Andriole, Jr., MD, and Robert E. Reiter, MD

Current and Emerging Liquid Diagnostics
E. David Crawford, MD

Treatment for Prostate Cancer with MRI-Guided Transurethral Ultrasound
Laurence Klotz, MD, FRCSC

High-Resolution 29 MHZ Micro-Ultrasound in Diagnosis of Primary and Recurrent Prostate Cancer
Gerald L. Andriole, Jr., MD

Panel Discussion
Moderator: Gerald L. Andriole, Jr., MD

MRI: Can It Be Used to Plan Ablative Therapies?
Robert E. Reiter, MD

Next Generation Imaging for Localization of Recurrent Prostate Cancer
Brian T. Helfand, MD, PhD

Updates on Imaging Technology for Group Practice
Jitesh Patel, MD

Panel Discussion
Moderator: Robert E. Reiter, MD

Poster Session – Oral Presentations
Moderator: TBD
(Top 10 posters presented for 5 minutes each)

Adjourn

Open/On Own

Saturday, July 17, 2021, ALL TIMES MOUNTAIN TIME

Registration Desk Opens

Exhibits Open

Educational Product Theater – Golden Cliff
Important Evidence-Based Changes in the Metastatic Castration-Sensitive Prostate Cancer Treatment Landscape
Speaker: Raoul S. Concepcion, MD

Supported by Astellas/Pfizer and Pfizer Oncology

Morning Break for Exhibits

SESSION 7: Advanced Prostate Cancer
Moderator: Daniel P. Petrylak, MD

Efficacy of Enzalutamide Plus ADT in Men with De Novo (M1) mHSPC Versus Progression to mHSPC: Post Hoc Analysis of the Phase III ARCHES Trial
Daniel P. Petrylak, MD

Final Results from ACIS Trial of Apalutamide Plus Abiraterone/Prednisone in Patients (pts) with Chemo-Naïve Metastatic Castration-Resistant Prostate Cancer (mCRPC)
R. Jonathan Henderson, MD

Safety of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer From Extended Follow-Up in the Phase III ARAMIS Trial
Raoul S. Concepcion, MD, FACS

Role of PARP Inhibitors
Daniel P. Petrylak, MD

Recent Advancement in the Treatment of Metastatic Castration Sensitive Prostate Cancer (mCSPC)
Neeraj Agarwal, MD

Panel Discussion
Moderator: Daniel P. Petrylak, MD

Morning Break for Exhibits

SESSION 8: Advanced Prostate Cancer
Challenging Cases and Breaking News
Moderator: Raoul S. Concepcion, MD, FACS

Introduction
Raoul S. Concepcion, MD

Real World Utilization of Guideline Based Therapy in mCSPC: Update from the 2021 ASCO Annual Meeting
Neeraj Agarwal, MD

Discussion

Phase 3 VERACITY Study: Sabizabulin, an Oral Targeted Androgen Receptor Transport Disruptor to Treat Men with Metastatic Castration Resistant Prostate Cancer Who Progressed on an Androgen Receptor Targeting Agent
Mitchell Steiner, MD

Discussion

Updates on PSMA-imaging and PSMA-CAR-T Therapy
Daniel P. Petrylak, MD

Discussion

GUIDE: A New Initiative for a National Biorepository
Matthew O. Leavitt, MD and E. David Crawford, MD

Discussion

Adjourn

Educational Product Theater – Golden Cliff
Navigate Prostate Cancer Management Decisions with Oncotype® Tests
Speaker: Brian Helfand, MD, PhD

Supported by Exact Sciences

Afternoon Break for Exhibits

SESSION 9: Targeted Focal Therapy
Moderator: Thomas J. Polascik, MD, FACS

MRI-Guided Focal Therapy: Initial Quality-of-Life and Oncologic Outcomes
James A. Eastham, MD, FACS

Transperineal Prostate Biopsy: A New Standard of Care?
Michael A. Gorin, MD

Recent Innovations in MRI-Guided Prostate Biopsy
Michael A. Gorin, MD

Panel Discussion
Moderator: Thomas J. Polascik, MD, FACS

Focal Brachytherapy
Steven E. Finkelstein, MD, FACRO

HIFU
Arvin George, MD

Cryotherapy
Thomas J. Polascik, MD, FACS

Surveillance After Image-Targeted Focal Therapy
Thomas J. Polascik, MD, FACS

Panel Discussion
Moderator: Thomas J. Polascik, MD, FACS
Panelists: E. David Crawford, MD; James A. Eastham, MD, FACS; Steven E. Finkelstein, MD, FACRO; Arvin George, MD; and Michael A. Gorin, MD

Adjourn

IPCU Cocktail Reception

Open/On Own

Sunday, July 18, 2021

Departures

Accommodations & Transportation

The Cliff Lodge is currently Sold Out, and there are no longer any available rooms remaining in the IPCU 31 block. To secure hotel accommodations near the Cliff Lodge in Snowbird, we encourage you to contact any of the following nearby options (availability may vary):

Lodging Health & Safety Measures from the Cliff Lodge

• Masks are required in communal indoor spaces, as well as outdoors when within the Snowbird Village, on the Tram, or while engaging in organized summer activities. Masks are not required when eating, swimming, hiking, or inside your hotel room. Masks are available for guests upon request.
• Enhanced hotel room cleaning with a focus on high-touch surfaces, including door handles, kitchen areas, refrigerators, faucets, toilets, remote controls, directories, telephones, and alarm clocks.
• Clean and disinfect high-touch surfaces in common areas, such as fitness centers, swimming pools, hot tubs, elevators, stairwells, restrooms, and escalators.
• Sanitize payment systems, pens, and front desk area after every guest.
• Remove non-essential items from hotel rooms, including magazines, notepads, and pens.

For more information, see The Cliff Lodge page with this link: https://www.snowbird.com/health-safety/

CONFERENCE ATTIRE:
Attire is business casual. Since meeting room temperatures and personal comfort levels vary, it is recommended that you bring a sweater or jacket to the educational activities.

PARKING:
Self-parking is complimentary for group attendees at all Snowbird lodges. Valet parking is available at the Cliff Lodge currently at $16.00 per day, per car. Prices are subject to change.

AIRPORT TRANSPORTATION:
Airport shuttles may be arranged while booking lodging through Snowbird Central Reservations (800-453-3000) or up to 48 hours prior to arrival. Current group round-trip pre-paid price is $78.00 per person. Walk-ups are accepted at a higher rate on a space-available basis at the Canyon Transportation desk located in the baggage claim area of the Salt Lake City International Airport. Cancellations received within 48 hours of arrival are non-refundable. Driver gratuity is not included and prices are subject to change.

TRIP INSURANCE:
Snowbird offers trip insurance on an individual basis for cancellations or travel interruptions. The insurance may be purchased through Central Reservations. It pays for charges assessed due to unforeseen circumstances or death, injury, or illness to the guest, or traveling companion. Insurance must be purchased at time of booking room reservation.

RECOMMENDED SUMMER ACTIVITIES:

• Alpine Slide – Race down 1,300 linear feet of twist and turns
• Mountain Coaster – Full of twists, turns, and horizontal loops, with 3,120 linear feet of excitement
• Aerial Tram Rides – Ride the Tram to the 11,000-foot summit of Hidden Peak
• Mountain Flyer – Fly down the 1000 foot zip line suspended above Chickadee
• Ropes Course
• Vertical Drop
• Bungy Trampoline – Bouncy fun in the sun
• Climbing Wall – 4-Station and Cliff Lodge climbing walls
• Hiking – Hikes and walks for all ability levels. Guided hikes upon request
• Mountain Bikes & Scooters – Hit the trails on bikes or scooters
• Kids Fishing Pond – Hunt the big ones in the Snowbird fishing pond
• Sports Equipment – Basketball, volleyball, badminton, horseshoe rentals
• Off-site adventures – Arrangements for river rafting or guided fly fishing trips on Utah’s most beautiful rivers
• Pool & Hot Tubs – Complimentary outdoor pools and hot tubs are heated and open year-round
• Fitness Room – Complimentary fitness room available
• Cliff Game Room – Hidden away on Level A is a spacious game room with billiard tables, air hockey, and a wide variety of video games
• Barrier-Free Trail – Snowbird features a wheelchair accessible, barrier-free trail. This one-mile round-trip nature walk begins at the Snowbird Plaza and ends at a beautiful observation deck overlooking the Gad Valley. Adults and children of all ages and abilities can enjoy this low impact hike.
• Horseback Riding – Guided horseback riding tours are available in the beautiful Mineral Basin
• Tennis Court

To view more information about summer activities in Snowbird, see this page from The Cliff Lodge: https://www.snowbird.com/summer-activities/

Invited Faculty

CME Information

This conference will be accredited for AMA PRA Category 1 Credits^TM.

Registration

During these times, Grand Rounds in Urology and the International Prostate Cancer Update are committed to you. This live event has been planned in accordance with state and local guidelines to meet the highest safety standards.

By registering for this conference, you agree to our standard Conference Registration and Attendance Terms and Conditions agreement, which is available online at: Conference Registration and Attendance Terms and Conditions.

• Please scroll through all the ticket options before making your selection.
• Don’t forget to add your promo code at the top left of the ticket list if you’re using one.
• Please make sure you fill out the registration form completely before you submit your registration, you will have to scroll below your name to see all the required information.

Health and Safety Precautions: The health and safety of IPCU attendees, faculty, sponsors, and staff are of the utmost importance to us. We are actively working with the host hotel to ensure proper safety and sanitary conditions. To that end, the following safety precautions will be in place:

• All participants will be asked to wear a mask when not eating or drinking.
• The general session room will be arranged to maintain social distancing.
• The general session room will be sanitized at the conclusion of the day and attendees will be asked to sit in their same seats from the day before.
• All food will be plated; there will be no buffet food service.
• Hotel staff will be wearing masks, as well as gloves when serving food.
• All meals and ancillary events outside of the general session will maintain social distancing.
• Sleeping rooms will be fully cleaned and sanitized between guests. Housekeeping will not enter your room during your stay. Guests will be able to obtain additional towels or other items upon request only.

We are monitoring all local and CDC guidelines and will make adjustments to these policies as necessary. For more information on Snowbird’s Commitment to Clean, please feel free to visit their cleanliness site: https://www.snowbird.com/health-safety/

If you have any questions, please contact Amy Collier at acollier@cjp.com

COVID-19 DISCLAIMER: An inherent risk of exposure to COVID-19 and other more common contagions exists in any public place where people are present. COVID-19 is an extremely contagious disease that can lead to severe illness and even death in a small percentage of the population, especially those with weakened immune systems. For your safety and convenience, we are endeavoring to take appropriate precautions, as detailed above. Even with our best efforts, however, there is no guarantee that you can avoid exposure to COVID-19 or other common pathogens, whether at our conference or elsewhere. Please note that, as further detailed in our Conference Registration and Attendance Terms and Conditions Agreement (the “Registration Agreement”), which must be reviewed and agreed to during the registration process, all conference attendees voluntarily assume ALL RISKS related to any possible exposure to COVID-19. We encourage you to read the Registration Agreement carefully, as it contains other important terms, including other disclaimers and limitations on liability.

Support Opportunities

To inquire about support opportunities, please contact:

Marc Weathersby, Chief Marketing Officer
Tel:434-817-2000, x193  •  Cell: 434-989-5508
Fax 434-817-2020  •  mweathersby@cjp.com

Exhibit and Sponsor Prospectus

Poster Submission

4. Who can give the oral poster presentation?
Anyone involved with the poster; it does not need to be a lead investigator or healthcare provider. However, please provide the name of the presenter to us in advance, by December 30, if possible.

5. Are the poster sessions CME accredited?
No

6. Are encore posters allowed?
Yes

7. I have other questions, who can I contact?
Amy at acollier@cjp.com or 703-944-2828.

NOTE: The posters will also be printed in an abstract book. Along with the abstract slide image itself, text similar to the following will be printed in the abstract book:

Jointly provided by Medical Education Resources (MER) and Carden Jennings Publishing Co., Ltd.

Featured Presentations from IPCU30

Virtual Access Instructions

Virtual access requires registration. If you have registered, you will have been sent a URL for the live stream. If you did not receive the email, please access live chat using the button on this page or email Amy Collier at acollier@cjp.com.

View content from previous International Prostate Cancer Update Meetings